Partnership aims to lower the cost of high-throughput screening

Share this on social media:

Integrated DNA Technologies (IDT) has announced that it is teaming up with 3CR Bioscience (3CR) to widen access to quality custom solutions for genotyping screening. The partnership combines IDT’s oligo synthesis with 3CR’s PACE Genotyping Master Mix and expertise in designing assays. Researchers will be able to work with a combined technical service team to design and order custom PACE SNP assays. The service will speed up and reduce the cost of high-volume genotyping, particularly useful for those working in the agricultural biotech sector.

The new PACE SNP assays join IDT’s innovative rhAmpSNP and rhAmpSeq technologies. For each PACE SNP assay, a technical service team made up of experts from both IDT and 3CR will work together to design the sequences for industry-leading IDT individually-synthesized oligos. Together, this will ensure the best possible assay design and manufacture for individual experiments. As well as improving reliability, the new service will lower the cost-per-sample compared to existing alternatives on the market.

Ben Viering, IDT Vice President of Business Development commented, 'IDT is excited to work with 3CR to help provide a complete genotyping solution. This is the latest in a series of partnerships, which we believe are a vital part of our mission to help make researchers lives easier. Our joint efforts provide a system that combines the superior performance of the 3CR master mix with high quality oligonucleotides from IDT. The combination provides a genotyping solution that is robust, highly sensitive, and economical.'

Agricultural biologists are set to particularly benefit from the partnership. The new service from IDT and 3CR is ideal for the high-volume genotyping screening that is often required for plant breeding experiments. The free PACE SNP assay design, from a technical team with over 40 years of experience in this area, will simplify the workflow, while generating more reliable data and at a lower cost.

Steve Asquith, Managing Director at 3CR Biosciences added, 'We look forward to partnering with IDT to help serve the genotyping needs of scientists. Our high-performance PACE master mix, based on a proprietary polymerase technology, pairs well with IDT’s quality oligo synthesis to provide a reliable genotyping solution. Combining IDT’s ability to synthesise oligos over a wide range of scales with our PACE master mix, which is suitable for all reaction volumes, allows customers to grow their projects from low- to high-throughput screening both easily and economically.'